2nd possible carcinogen found in recalled blood pressure drug valsartan, Health Canada says
A second impurity that is a classified as a probable human carcinogen has been found in valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in China, Health Canada announces.
No comments:
Post a Comment